TB
Treeline Biosciences
Developing novel therapeutics for challenging diseases using advanced biological insights.
About
Treeline Biosciences is a biotechnology company focused on discovering and developing new medicines for diseases with high unmet medical needs. They leverage a deep understanding of biological pathways and cutting-edge research to create innovative therapeutic candidates.
Technology stack
detected 2026-06-18Est. monthly stack spend~$70/mo
Emailunknown
Comments
No comments yet. Be the first to share your take.
Frequently asked
What does Treeline Biosciences do?
Treeline Biosciences is a biotechnology company focused on discovering and developing new medicines for diseases with high unmet medical needs. They leverage a deep understanding of biological pathways and cutting-edge research to create innovative therapeutic candidates.
How much funding has Treeline Biosciences raised?
Treeline Biosciences has raised a total of $300M in funding. The most recent round on record is Series B.
Where is Treeline Biosciences headquartered?
Treeline Biosciences is headquartered in Cambridge, United States.
When was Treeline Biosciences founded?
Treeline Biosciences was founded in 2019.
What industry does Treeline Biosciences operate in?
Treeline Biosciences operates in Biotech, MedTech, Drug Discovery, Clinical Trials, Therapeutics.